GeneDx Holdings annual shares outstanding
2022
2023
2024
2025
GeneDx Holdings Shares Outstanding History (WGS)
GeneDx Holdings reported 29.2M shares outstanding at the end of fiscal 2025.
View full GeneDx Holdings company overviewGeneDx Holdings annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 29.2M | 1.2M | +4.39% |
| 2024 | 2024-12-31 | 28.0M | 2.0M | +7.84% |
| 2023 | 2023-12-31 | 26.0M | 14.2M | +120.66% |
| 2022 | 2022-12-31 | 11.8M | — | — |
GeneDx Holdings quarterly shares outstanding
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 29.8M | 1.1M | +3.81% |
| Q1 2026 | 2026-03-31 | 29.7M | 1.1M | +3.98% |
| Q4 2025 | 2025-12-31 | 29.2M | 1.2M | +4.39% |
| Q3 2025 | 2025-09-30 | 28.9M | 1.5M | +5.31% |
| Q2 2025 | 2025-06-30 | 28.7M | 1.8M | +6.62% |
| Q1 2025 | 2025-03-31 | 28.5M | 2.4M | +9.22% |
| Q4 2024 | 2024-12-31 | 28.0M | 2.0M | +7.84% |
| Q3 2024 | 2024-09-30 | 27.4M | 26.7M | +3434.09% |
| Q2 2024 | 2024-06-30 | 26.9M | 26.9M | +116036.92% |
| Q1 2024 | 2024-03-31 | 26.1M | 26.1M | +133299743.58% |
| Q4 2023 | 2023-12-31 | 26.0M | 26.0M | +272424033.99% |
| Q3 2023 | 2023-09-30 | 776,261.67 | 776,252.401 | +8374966.56% |
| Q2 2023 | 2023-06-30 | 23,185.032 | 23,175.801 | +251051.51% |
| Q1 2023 | 2023-03-31 | 19.597 | 13.639 | +228.95% |
| Q4 2022 | 2022-12-31 | 9.536 | 3.64 | +61.73% |
| Q3 2022 | 2022-09-30 | 9.269 | — | — |
| Q2 2022 | 2022-06-30 | 9.231 | — | — |
| Q1 2022 | 2022-03-31 | 5.957 | — | — |
| Q4 2021 | 2021-12-31 | 5.896 | — | — |
GeneDx Holdings shares outstanding trends
Across the available reported history, GeneDx Holdings's shares outstanding moved from 28.0M to 29.2M, a change of 1.2M. The latest reported quarter, Q2 2026, shows 29.8M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GeneDx Holdings filings at SEC.gov ↗